Many upregulated genes such as cancer stem cell marker (SOX2/9), hypoxia inducible factor (HIF1α), TGF-β signaling associated receptor (TGFBR2), and differentiation related transcription factor (RUNX2) were reported to promote tamoxifen resistance [21–24]. This evidence concerns the gene HIF1A and cancer.